News | October 12, 2022
Merck recognized on Fortune’s 2022 change the World List
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
Earlier today, the Foundation for the National Institutes of Health (FNIH) announced that Dr. Gerberding will become CEO of the FNIH on May 16
In the interim, Deepak Khanna will lead Human Health International.
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic
Subscribe To Our Newsletter & Stay Updated
